Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 29: 853-856, 1983;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parviainen, M. T.
Right arrow Articles by Ylitalo, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parviainen, M. T.
Right arrow Articles by Ylitalo, P.

Clinical Chemistry, Vol 29, 853-856, Copyright © 1983 by American Association for Clinical Chemistry

Immunonephelometric determination of retinol-binding protein in serum and urine

MT Parviainen and P Ylitalo

An immunonephelometric method developed for measurement of retinol- binding protein (RBP) in serum and urine can detect it in concentrations of about 30 micrograms/L, which is in the lower limit of its normal concentration in urine (range 0-0.56 mg/L; mean +/- SD 0.19 +/- 0.15; n = 44). Urinary RBP was increased (range 0.93-29.5 mg/L) in all of 25 urine specimens from 13 subjects being treated with aminoglycoside (tobramycin). Urinary excretion of RBP was correlated (r = 0.83) with the excretion of beta 2-microglobulin. The within-assay and day-to-day precision (CV) was determined over the detection range of 0.03-8 mg/L. Within these limits the corresponding CVs varied from 4 to 27% and from 8 to 30%, respectively. The method had fairly good precision within the optimal measuring range of approximately 0.4 to 4.5 mg/L for both urine and 20-fold diluted serum samples. For various RBP concentrations our analytical recovery was 89-114% of added RBP. Results by this method correlated well (r = 0.96, n = 24) with those by a radial immunodiffusion method.


The following articles in journals at HighWire Press have cited this article:


Home page
 Am. J. Clin. Nutr.Home page
J. M Baeten, B. A Richardson, D. D Bankson, M. H Wener, J. K Kreiss, L. Lavreys, K. Mandaliya, J. J Bwayo, and R S. McClelland
Use of serum retinol-binding protein for prediction of vitamin A deficiency: effects of HIV-1 infection, protein malnutrition, and the acute phase response
Am. J. Clinical Nutrition, February 1, 2004; 79(2): 218 - 225.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
N. E. Craft
Innovative Approaches to Vitamin A Assessment
J. Nutr., May 1, 2001; 131(5): 1626S - 1630.
[Abstract] [Full Text]

Home page
 Am. J. Clin. Nutr.Home page
M. V Gamble, R. Ramakrishnan, N. A Palafox, K. Briand, L. Berglund, and W. S Blaner
Retinol binding protein as a surrogate measure for serum retinol: studies in vitamin A-deficient children from the Republic of the Marshall Islands
Am. J. Clinical Nutrition, March 1, 2001; 73(3): 594 - 601.
[Abstract] [Full Text] [PDF]

Home page
 Indoor and Built EnvironmentHome page
S. Attenoux-Merono, J. Pompili, A. Botta, F. Grimaldi, E. Muls, and A. Viala
Urinary Effects of Metallic Air Pollutants on School Children
Indoor and Built Environment, January 1, 1994; 3(1): 35 - 38.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the American Association for Clinical Chemistry.